Table 3.
Univariate and multivariate analyses for the training set
| Variable | Univariate | Multivariate | HR (95%CI) |
| Sex | 0.525 | - | - |
| Age | 0.062 | - | - |
| Albumin | 0.816 | - | - |
| Platelet count | 0.094 | - | - |
| MELD | 0.874 | - | - |
| Tumor size in explant | 0.059 | - | - |
| Number of tumors in explant | 0.007 | NS | - |
| Microvascular invasion | 0.895 | - | - |
| Well/mod differentiation | 0.811 | - | - |
| Serum AFP level before LT ( ≥ 400 ng/mL) | 0.002 | 0.012 | 2.92 (1.487-5.748) |
| Graft (g)/ESLW | 0.083 | - | - |
| Waiting time from listing to transplantation | 0.77 | - | - |
| Salvage LT | 0.019 | 0.033 | 2.08 (1.063-4.081) |
| Milan criteria | 0.052 | NS | - |
| UCSF criteria | 0.009 | NS | - |
| Sum of tumor size and number | 0.002 | 0.013 | 1.15 (1.03-1.28) |
MELD: Model for end stage liver disease; Well/mod differentiation: Well or moderate differentiation; CI: Confidence interval; AFP: Alpha fetoprotein; LT: Liver transplantation; ESLW: Estimated standard liver weight; UCSF: University of California at San Francisco.